Evidence map›Paper›PMID 37021068›Full record

ReviewExperimental and therapeutic medicine2023

Research advances in crosstalk between muscle and bone in osteosarcopenia (Review).

Chen Yu, Yongjun Du, Zhi Peng, Chengjie Ma, Junhua Fang, Langtao Ma, Fei Chen, Chaoqun Zhang, Ruizhi Geng, Yangyang Zhang and 4 more

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Experimental and therapeutic medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Chen YuOrthopedics Department, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650034, P.R. China.
Yongjun DuOrthopedics Department, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650034, P.R. China.
Zhi PengOrthopedics Department, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650034, P.R. China.
Chengjie MaOrthopedics Department, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650034, P.R. China.
Junhua FangOrthopedics Department, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650034, P.R. China.
Langtao MaOrthopedics Department, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650034, P.R. China.
Fei ChenOrthopedics Department, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650034, P.R. China.
Chaoqun ZhangGraduate School, Kunming Medical University, Kunming, Yunnan 650500, P.R. China.
Ruizhi GengGraduate School, Kunming Medical University, Kunming, Yunnan 650500, P.R. China.
Yangyang ZhangGraduate School, Kunming Medical University, Kunming, Yunnan 650500, P.R. China.
Xi HanGraduate School, Kunming Medical University, Kunming, Yunnan 650500, P.R. China.
Jiayi LiGraduate School, Kunming Medical University, Kunming, Yunnan 650500, P.R. China.
Yan LvOrthopedics Department, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650034, P.R. China.
Sheng LuOrthopedics Department, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650034, P.R. China.
First People's Hospital of Yunnan Province · CNKunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteosarcopenia is a burgeoning geriatric syndrome and a familiar disease among older individuals. It is characterized by reduced skeletal muscle mass and bone mineral density due to osteoporosis and sarcopenia. Its clinical manifestations include reduced physical performance and individuals becoming prone to falls during the aging process resulting in fractures and hospitalization, which seriously affects the quality of life of patients and increases the risk of death. Due to the aging social structure of the global population, the morbidity of osteosarcopenia is expected to continue to increase. Both muscle and bone belong to the motor system and originate from the mesoderm; therefore, sarcopenia and osteoporosis also share similar pathogenical factors, which influence and regulate each other. Studying the pathogenesis and treatment of osteosarcopenia is of great significance to improve the quality of life of patients. Therefore, the present study reviewed the research progress on sarcopenia and osteoporosis in osteosarcopenia from the standpoints of its definition, epidemiology, clinical manifestations and diagnosis, prevention and treatment.

Indexed as

bonecrosstalkmuscleosteosarcopeniaquality of lifesyndrome

Identifiers

PMID37021068
PMCPMC10067545
OpenAlexW4324192647

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.